Introduction
Methods
Results
Conclusions
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Preventive MedicineReferences
- Impact of socioeconomic status on hospital use in New York City.Health Aff (Millwood). 1993; 12: 162-173https://doi.org/10.1377/hlthaff.12.1.162
- Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland.JAMA. 1992; 268: 2388-2394https://doi.org/10.1001/jama.1992.03490170060026
- Potentially preventable hospitalizations—United States, 2001-2009.MMWR Surveill Summ. 2013; 62: 139-143
- Preventable hospitalizations for hypertension: establishing a baseline for monitoring racial differences in rates.Prev Chronic Dis. 2013; 10: 120165https://doi.org/10.5888/pcd10.120165
- Race, ethnicity and hospitalization for six chronic ambulatory care sensitive conditions in the USA.Ethn Health. 2006; 11: 247-263https://doi.org/10.1080/13557850600565640
- Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks.Am J Public Health. 2003; 93: 447-455https://doi.org/10.2105/AJPH.93.3.447
Russo CA, Andrews RM, Coffey RM. Racial and ethnic disparities in potentially preventable hospitalizations, 2003: Statistical brief #10. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Policy and Research; 2006.
- Geographic and racial patterns of preventable hospitalizations for hypertension: Medicare beneficiaries, 2004-2009.Public Health Rep. 2014; 129: 8-18
- Racial disparities in hospitalizations for ambulatory care-sensitive conditions.Am J Prev Med. 2010; 38: 381-388https://doi.org/10.1016/j.amepre.2009.12.026
- Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention.Stroke. 2009; 40: 213-220https://doi.org/10.1161/STROKEAHA.108.522193
- Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO).J Hypertens. 2014; 33: 412-420https://doi.org/10.1097/HJH.0000000000000382
- Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.Circulation. 2009; 120: 1598-1605https://doi.org/10.1161/CIRCULATIONAHA.108.830299
- Better adherence to antihypertensive agents and risk reduction of chronic heart failure.J Intern Med. 2009; 266: 207-218https://doi.org/10.1111/j.1365-2796.2009.02084.x
- Adherence level of antihypertensive agents in coronary artery disease.Br J Clin Pharmacol. 2010; 69: 74-84https://doi.org/10.1111/j.1365-2125.2009.03547.x
- Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death.J Gen Intern Med. 2010; 25: 495-503https://doi.org/10.1007/s11606-009-1240-1
- Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.Med Care. 2010; 48: 418-425https://doi.org/10.1097/MLR.0b013e3181d567bd
- Impact of medication adherence on hospitalization risk and healthcare cost.Med Care. 2005; 43: 521-530https://doi.org/10.1097/01.mlr.0000163641.86870.af
- Better compliance to antihypertensive medications reduces cardiovascular risk.J Hypertens. 2011; 29: 610-618https://doi.org/10.1097/HJH.0b013e328342ca97
- Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients.Clinicoecon Outcomes Res. 2011; 3: 47-54https://doi.org/10.2147/CEOR.S15619
Danielson E. White paper: Health research data for the real world: the MarketScan Databases. http://truvenhealth.com/Portals/0/Users/031/31/31/PH_13434%200314_MarketScan_WP_web.pdf. Published January 2014. Accessed March 18, 2015.
Chronic Conditions Warehouse. Centers for Medicare and Medicaid Services. www.ccwdata.org/web/guest/condition-categories. Accessed March 18, 2015.
Medication Management Measures. The National Quality Forum. www.qualityforum.org/Publications/2010/05/National_Voluntary_Consensus_Standards_for_Medication_Management.aspx. Accessed March 18, 2015.
- Proportion of days covered (PDC) as a preferred measure of medication adherence.Pharmacy Quality Alliance. 2015; (Accessed March 18, 2015)
- Measuring concurrent adherence to multiple related medications.Am J Manag Care. 2009; 15: 457-464
- Bureau of Health Professions.Area Health Resources Files (AHRF). 2015; (Accessed March 18, 2015)
- A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.J Chronic Dis. 1987; 40: 373-383https://doi.org/10.1016/0021-9681(87)90171-8
- Performance of comorbidity measures to predict stroke and death in a community-dwelling, hypertensive Medicaid population.Stroke. 2008; 39: 1938-1944https://doi.org/10.1161/STROKEAHA.107.504688
Agency for Health Care Research and Quality. Prevention quality indicators technical specifications. www.qualityindicators.ahrq.gov/modules/pqi_resources.aspx. Accessed March 18, 2015.
- A meta-analysis of the association between adherence to drug therapy and mortality.BMJ. 2006; 333: 15https://doi.org/10.1136/bmj.38875.675486.55
Bureau of Economic Analysis. Domestic product and income, Table 1.1.4. www.bea.gov/iTable/iTable.cfm?ReqID=9&step=1#reqid=9&step=3&isuri=1&903=4. Accessed March 18, 2015.
- Regression models and life-tables.J R Stat Soc Series B. 1972; 34: 187-220
- Generalized linear models.J R Stat Soc Series A. 1972; 135: 370-384https://doi.org/10.2307/2344614
- Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults.Med Clin North Am. 2009; 93: 753-769https://doi.org/10.1016/j.mcna.2009.02.007
- Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2).Med J Aust. 2006; 185: 487-489
- The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke.Curr Med Res Opin. 2008; 24: 121-127https://doi.org/10.1185/030079908X253843
- Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease.Am Heart J. 2008; 155: 772-779https://doi.org/10.1016/j.ahj.2007.12.011
Viswanathan MGC, Jones CD, Ashok M, et al. Medication Adherence Interventions: Comparative Effectiveness. Closing the Quality Gap: Revisiting the State of the Science. Evidence Report No. 208. (Prepared by RTI International–University of North Carolina Evidence-based Practice Center under Contract No. 290-2007-10056-I.) AHRQ Publication No. 12-E010-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm. Accessed March 18, 2015.
- A practice-based trial of motivational interviewing and adherence in hypertensive African Americans.Am J Hypertens. 2008; 21: 1137-1143https://doi.org/10.1038/ajh.2008.240
- Developing alternative methods for determining the incidence, prevalence, and cost burden of coronary heart disease in a corporate population.J Occup Environ Med. 2012; 54: 1026-1038https://doi.org/10.1097/JOM.0b013e318256f636
- Factors affecting medication adherence: patient perspectives from five veterans affairs facilities.BMC Health Serv Res. 2014; 14: 533https://doi.org/10.1186/s12913-014-0533-1
- Dispensing channel and medication adherence: evidence across 3 therapy classes.Am J Manag Care. 2013; 19: 798-804